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Abstract We provide evidence in this study that the 86-bp insert 
in the/$L2 mRNA isoform of the voltage gated sodium channel 
is an intron. Transcripts still retaining this intron were detected 
in all tissues where the IBI gene expression was investigated. We 
also show that the exon/intron boundaries of the last two introns 
are conserved among rat, mouse and human ~1 gene. Unlike the 
highly conserved cDNAs, introns in only the rat and mouse genes 
are highly related. The last intron is very short (86-90 bp) and 
is located in the 3' untranslated sequence, both uncommon prop- 
erties of mammalian pre-mRNA introns. 
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1. Introduction 
Voltage-gated Na ÷ channels from rat brain are composed of 
three subunits: ~ (260 kDa), fll (36 kDa) and/32 (33 kDa) [1,2]. 
A number of :z subunits have been identified and are encoded 
by members of an expanding ene family [2 5]. Specific ~z sub- 
units are expressed in a tissue-specific and developmentally 
specific manner [6,7]. Expression of the ~ subunit alone in 
Xenopus oocytes is sufficient to produce functional channels: 
however, the co-expression of the fll subunit results in a Na + 
current with properties closer to those of native channels [1]. 
Clones of the fll cDNAs have been obtained from rat and 
human [8 10] and were shown to be highly conserved at the 
nucleotide and amino acid levels. The sequence of the f12 sub- 
unit has not yet been published and its function is yet to be 
clarified. 
In an earlier study, restriction enzyme analysis, cloning and 
sequencing of i l l  cDNA from rat sciatic nerve, which does not 
contain neurons and thus is presumably derived from Schwann 
cells, revealed the presence of two isoforms fl~ ~ and fl~,_ [11]. 
Amplification of similar DNA fragments is also reported from 
embryonic rat tissues [12]. In the present study we used RT- 
PCR and genomic PCR to investigate the presence of the two 
fll isoforms and to determine the source of ilL> In an attempt 
to determine if the fll subunit is encoded by members of a gene 
family, we analysed cDNA fragments that were amplified by 
RT-PCR from various adult rat tissue RNAs. We also ampli- 
fied and compared portions of the fll gene from rat, mouse and 
human genomic DNA. We present here evidence that fl~ z is an 
incompletely spliced RNA and confirm one of the polymorphic 
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sites that were previously reported [11]. We also report on the 
relatedness of the last two introns in this gene among the three 
species. 
2. Materials and methods 
2.1. Cell culture. B104 
The BI04 neuroblastoma cell line was obtained from D. Schubert 
(Salk Institute, La Jolla, CA). Cells were cultured in Dulbecco's Mod- 
ified Eagle's Medium supplemented with 20% fetal calf serum [13]. 
Penicillin and streptomycin were added at 500 U/ml each. Cells were 
grown in 5-ml flasks (source) at 37°C in a 5% COf195% air atmos- 
phere. 
2,2. Nucleic acid isolation 
Total cellular RNA was isolated by the single step Guanidinum 
isothiocyanate-acid phenol procedure [14] The quality of the RNA was 
assessed by electrophoresis in a 1% agarose-2.2 M formaldehyde gel 
[15]. High molecular weight DN A was isolated from liver tissue of adult 
Sprague-Dawley rats as described [15]. Mouse and human high molec- 
ular weight DNA were purchased from Clontech (Palo Alto, CA). 
2.3. Reverse transcription 
First-strand cDNA was reverse transcribed in a 50/11 final volume 
using 5/tg total RNA, 1 FtM random hexamer (Boehringer Mannheim) 
and 500 U SuperScript II reverse transcriptase (Life Technologies) in
the presence of 100 U of RNase Inhibitor (Boehringer Mannheim). The 
reaction buffer consisted of 50 mM Tris-HC1 (pH 8.3), 75 mM KCI, 
3 mM MgCl> 10 mM DTT and 5 mM dNTE The reaction was allowed 
to proceed at 37°C for 90 min, 42°C for 30 min then terminated by 
heating to 65°C for 10 min. A control reverse transcription reaction 
contained all components except for reverse transcriptase. 
2.4. PCR 
We used nested primers for both RT-PCR and genomic PCR to 
reduce non-specific amplification. The same primer set was used in the 
primary PCR of the two applications. The 5' oligonucleotide primer (A) 
(5' GATATGGCATCCATCGTGTC 3') corresponds to nucleotides 
676- 685 (rat) and 554~573 (human) while the 3' oligonucleotide primer 
(B) (5' CCAGGTCCAGCCGGAGGAAGC 3") corresponds tonucleo- 
tides 1325 1345 (rat) and 1239 1259 (human) [8,9]; this sequence is 
completely conserved between rat and human and is expected to also 
be conserved in the mouse. The 5' primer has a mismatch (C to T) at 
position 3 compared with the human sequence. This difference is not 
expected to affect he priming efficiency under the PCR conditions used 
in this study. 
For RT-PCR, the primer set of the secondary PCR is expected to 
amplify sequences between positions 810 and 1255 of the cDNA (num- 
bers according to [8]). The 5' primer (C) (5' CTCGGAATACCTG- 
GCCAT 3') and the 3' primer (D) (5' CCCTCTTCACCCCATCAAG 
3') correspond to nucleotides 810-827 and 1271 1255, respectively [8]. 
The amplified fragment is predicted to be 445 bp in length. 
For secondary genomic PCR. the 5" oligonucleotide primer (A) is the 
same primer used for primary PCR. The 3' oligonucleotide primer (ER) 
(5' ACTGCAGAACTGTGAGGCT 3') correspond to nucleotides 
1000-1018 (rat) and (E u) (5' CAGGACTCTGAGGCTTTCT 3') corre- 
spond to nucleotides 852-870 (human). The 3' ends of these primers are 
complementary to different sequences in rat and human and, therefore, 
do not efficiently prime the template under the stringent amplification 
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M 1 2 34  S 6 M conditions utilized in this study (data not shown). Mouse fll sequencc are not available but we assumed that they will be highly related to 
those of the rat sequence. 
Rat fl-actin sequences were amplified from the same cDNA pool, 
using commercial primers (Clontech) to determine the presence of con- 
taminating enomic DNA in the RNA preparations. PCR from a 
cDNA template results in a 764-bp fragment while a genomic template 
results in a 1440-bp fragment. A single DNA fragment, comigrating 
with the 800-bp molecular weight marker, is detected in control PCR 
reactions which indicates the absence of appreciable genomic DNA 
contamination i the RNA samples (data not shown). 
Amplification was typically performed in 60/al volume using 1/al of 
the first-strand cDNA or 100 ng genomic DNA template, 0.8/aM of 
each primer and 1.75 U of Expand Long Template DNA polymerase 
enzyme mixture (Boehringer Mannheim). Control PCR reactions in 
which the template was substituted by water or an aliquot from a 
control reverse transcription reaction lacking reverse transcriptase pro- 
duced no amplification products (data not shown). The use of the 
Expand Long Template nzyme mixture increased the yield of the PCR 
products without an increase in non-specific amplification [16,17]. The 
PCR reaction buffer consisted of 50 mM Tris-HCl (pH 9.2), 16 mM 
(NH4)2SO4, 2.25 mM MgCl:, 2% (v/v) DMSO and 0.1%, Tween-20. 
Amplification was carried out in two stages using a programmable 
thermal cycler (PTC-100, MJ Research, Cambridge, MA). First, 
a denaturation step at 94°C for 4 rain, an annealing step at 58°C for 
2 rain and an elongation step at 72°C for 90 s. Second, a denaturation 
step at 94°C for 1 min, an annealing step at 58°C for 1 rain and an 
elongation step at 72°C for 90 s. The second stage was repeated 33 times 
for a total of 35 cycles with the elongation step in the last cycle extended 
to 10 rain. Secondary PCR was performed essentially as described 
above except hat the template was a 1/al of a 1:500 (genomic PCRt 
and 1:1000 (RT-PCR) dilution of the primaD PCR product and ampli- 
fication was carried out for 25 c3.cles. 
2.5. Cloning and sequence analysL~ 
Rat genomic PCR products were cloned into the SmaI site of 
pBluescript II (KS) vector (Stratagene). Mouse and human genomic 
PCR products were cloned into the Srfl site in the vector pCR-Script 
AMP (KS +) (Stratagene). Inserts of three independent isolates of rat 
and mouse and one isolate of human PCR products were sequenced 
using an automated sequencer at the Keck Biotechnology Laboratory 
at Yale University. The sequences were analysed using software from 
the Genetics Computer Group. 
3. Results and discussion 
Recently, we described a novel fll subunit RNA isoform 
(fl12) from rat brain, optic nerve, sciatic nerve and skeletal 
muscles that contains several nucleotide substitutions and an 
86 nt insert in the 3' untranslated [11]. PCR amplification of 
cDNAs from brain, spinal cord, dorsal root ganglia (DRG) and 
the neuroblastoma cell line B104 (Fig. l) reveals the presence 
of the two/31 isoform RNAs (Fig. 1). Lanes 2-6 contain frag- 
ments from the secondary RT-PCR reaction using primer pair 
C/D and the following templates: forebrain (lane 2), hindbrain 
(lane 3), spinal cord (lane 4), DRG (lane 5) and BI04 cells (lane 
Table 1 
Percentage nucleotide similarity in the exons and introns of the ampli- 
fied fll gene fragments from rat, mouse and human 
Exon 4 lntron 4 Exon 5 Intron 5 Exon 6 
rat Vs mouse 95.5 87 95.8 93 97 
rat Vs human 95.5* 46.5 '" 88.9 46.5 55 
mouse Vs human 91.5 s 61 ~' 86 41 54.5 
*Deduced from the published sequences [10] and this study. 
'~Based on the partial sequence available for the human fll intron 4 
from this study. 
SAlthough the overall similarity is the same, the different positions are 
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Fig. I. RT-PCR amplification of Na channel fll subunit sequences. 
Secondary PCR products from forebrain (lane 1), hindbrain (lane 2), 
spinal cord (lane 3), DRG (lane 4) and B104 cells (lane 5). Lane 6 
contains amplification products using water as a template. The lower 
band represents amplification products from the mature, fully spliced 
/~1 mRNA. The top band is that expected from an amplification prod- 
uct of a template retaining intron 5. The reason for the appearance of
two top bands is not clear to us at this time. 
6). Lane 7 contains PCR product using water as a template. The 
size of the DNA fragments in these lanes is in agreement with 
the expected sizes of 445 bp and 531 bp of f lu  and ill.> respec- 
tively. The presence of the two transcripts in forebrain, hind- 
brain, spinal cord and DRG (each of which contain neuronal 
cell bodies and glial cells), and BI04 cells (a neuroblastoma cell 
line) as well as rat optic and sciatic nerves (which contain glial 
and Schwann cells but no neuronal cell bodies) argues against 
the possibility that this is a gila-specific phenomenon. It ap- 
pears that the two forms coexist in all of the tissues where the 
fll gene expression is tested. However, this data does not dem- 
onstrate the co-existence of the two transcripts in the same cell. 
Based on its sequence and transcription pattern, the insert 
in the ilL2 isoform is a pre-mRNA intron. Eukaryotic pre- 
mRNA introns are characterized by GT as the 5' dinucleotide, 
AG as the 3' dinucleotide preceded by a polypyrimidine-rich 
tract of about 14 bp and a branch site that has the loose motif  
C/TTA/GA*C/T (the A marked by an asterisk is the branch 
nucleotide ) located typically 20 30 bp upstream of the 3' splice 
site ([18] and references therein). The sequence of the 86 nucle- 
otide insert in fl~: (Fig. 2, [11]) contains all of these hallmarks. 
Consistent with its splicing, transcripts lacking this insert ac- 
count for the majority o f thef l l  mRNA ([11,12] and this study). 
Additionally, the human ,81 gene structure has already been 
published and an intron of 90 bp (intron 5) is reported to be 
present at precisely the same location as the insert in/31.2, but 
the complete sequence of this intron was not reported [19]. 
Like the human gene [10], rat and mousef l l  subunit is likely 
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to be encoded by a single gene. In support of this view, the 
sequences of three independent isolates from the amplification 
product, including the introns, were identical for the rat and 
mouse, respectively. Intron sequence variation has been re- 
ported even in the relatively recent gene duplicates ~1 and ce2 
of the human ~-globin genes [20] and the MCP-I and MCP-2 
rabbit defensin genes [21]. The presence of introns 4 and 5 in 
all three isolates strongly suggests the absence of a completely 
processed pseudogene in the rat and mouse genomes. The addi- 
tional two cytosine residues at position 912 of the cDNA that 
was reported earlier [11] are also present in these genomic 
isolates• The difference between this sequence and original pub- 
lished sequence may identify a polymorphic site in this gene. 
We found that the position of introns 4 and 5 in the human 
gene is conserved in the rat and mouse genes• Intron 4 from rat 
and mouse genes show 87% identity which is lower than that 
of intron 5 and the flanking exon sequences (Table 1). Intron 
4 in the human gene apparently contains a recognition site for 
the restriction endonuclease Srf l  because we did not recover 
sequences from exon 4, which contains the sequence of the 
upstream PCR primer, and a portion of this intron. Based on 
the comparable size of the amplified fragment from the three 
genomic DNAs (data not shown) we estimate that we are miss- 
ing around 100 bp of this intron. Intron 4 from the human gene 
is only 46.5% and 61% identical to intron 4 from the rat and 
mouse genes, respectively (Table 1). In contrast, exon 4 from 
the human gene is 91.5% identical, at the nucleotide sequence 
level, compared with the rat and mouse exon 4 (Table 1). The 
reduction in similarity relative to the flanking exon sequences 
is not surprising since intron primary sequences tolerate 
changes except at the conserved splicing signals [22]. The simi- 
larity of the introns between rat and mouse genomes is also not 
surprising given that they are known to have nearly equal 
mutation rates [23]. 
The sequence of intron 5 in the three species is shown in Fig. 
2. Analysis of this data shows that mouse fll intron 5 is 87 bp 
, ~T~T???T~C~?T?T?~U`AT '~`~`~?T~`c~T`~'~T~T~. -~T~T~`~`?~. f~?~?T?T??~T~U ~ 
*¢ 
101 CT@CTGCCACGG~C~GCTGCAC~G~TGCgt  gagr ~ggg. t ~g~ agg~ag ~c,:9(~Qgcgacc t ag~tgccat  c gt  cgct  cagagt  a tc tgt  ~ 
. . . . . . .  ~ . . .  C. . . . . . . . . . . . . . . . .  C . . . . . . . . . . . . . . . . .  . . . . . .  ,~  . . . . . . . . . . . . .  : . . . . . . . . . . . .  
301 aaggct  t c~ggt  tgg  . . . .  
. . . c . . :  . . . . . .  ngagt ta  . . . . .  :~  . . . .  a a ~ ~ ' a . .  t . . . . . .  : . . . . . . .  
5Cl : t cagggt tg~g~c~agg~tcactg~t~ I~t~t )~s  agC~ GG~A<~G~A~AC~G~GC~A~C~G~A~A~ 
601 GTCCAGGTGC.CTGAATAGfGCTGgtaaggt tga :g~a C~:T----, ~CtgC~:~ ~ZZ~g ~gg~tcagg~,azacte  taaqtc tc : :~-  
801 ZCTGGCA~TGG~C~ATCA3CCCAT CC, GT  ] [ :'UCC n 5 - ~ - -~  :a AGTT~T~ n 
Fig. 2. Alignment of the rat, mouse and human sequences. The top, 
middle and bottom lines are the rat, mouse and human sequences. 
respectively. We only show the portion of intron 4 of the human gene 
that could be reliably aligned with the rat and mouse sequences: the 
remaining available sequence is deposited in the GenBank data base. 
Exon and intron sequences are in upper and lower case type, respec- 
tively. This alignment was generated by the GAP program of GCG. 
Dots and dashes represent identities and deletions, respectively. Exon/ 
intron boundaries are identified by the arrow heads and were deter- 
mined for the human and rat sequences by comparison to published 
cDNA and genomic sequences, and lbr the mouse b;y homology to the 
rat sequences. These sequences are deposited in the GenBank database 
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Fig. 3. Predicted secondary structure of intron 5 from rat, mouse and 
human fll gene. This figure shows the predicted secondary structure of 
intron 5 from rat (a), mouse (b) and human (c). These structures were 
determined by computer analysis using the FOLD program of GCG. 
The stability of the structure was calculated at -24.7 kcal/mol, - 16.8 
kcal/mol and - 37.1 kcal/mol for the rat, mouse and human sequence, 
respectively• Only the nucleotides at the 5'and 3' splice sites and the 
putative branch site are shown. The second A in the branch site motif 
(denoted by an *) is the branch residue. 
long and is highly conserved relative to its rat cognate. Intron 
5 from the rat and mouse genes share 93% sequence identity 
while they share only 46.5% and 41% identity with the human 
cognate (90 bp long), respectively (Table 1). The sequence of 
the human intron 5 from our study is identical to the corre- 
sponding published sequence [19]. The divergence between the 
human and rat sequences i in stark contrast with the conserva- 
tion of the coding sequences (90%) and the 3' untranslated 
sequences (67%) previously reported [9,10]• Rat and human 
exon 6 sequences that were obtained in this study were 55% 
identical to each other (Table 1). This reduced identity com- 
pared with the 67% figure cited above is due to the selection of 
a more divergent region of the 3' untranslated sequences to 
enhance the selectivity of the amplification process in our study. 
The location of intron 5 is uncommon among vertebrate 
genes which rarely contain introns in their 3' untranslated se- 
quences [24,25]. Also, the length of intron 5 (86-90 bp) is more 
typical of internal introns than of introns occurring in the 3' 
untranslated sequences [24]. Intron 5 is the shortest intron in 
the human fll gene [19] and, interestingly, the only intron to be 
retained in the fl12 mRNA isoform ([11,12] and this study). The 
presence offl~.z RNA is consistent with recent published reports 
which demonstrate the accumulation of unspliced, polyadenyl- 
ated RNA as an intermediate during mRNA maturation [26]; 
the presence of a functional terminal intron is essential for the 
selection of a polyadenylation site and proper 3' end formation 
[271. 
Several cases of intron retention has been reported in the 
literature [28-31]. Retained introns could maintain the open 
reading frame and result in an alternate protein [29,30]. In the 
case of  the bovine growth hormone, intron retention is depend- 
ent on suboptimal 5' and 3' splice sites [29,32]. Intron 5 of i l l  
has optimal splice sites, a polypyrimidine-rich tract and a 
branch site. Therefore, its retention is not likely to be caused 
by an inefficient spliceosome complex assembly. Intron 5 in the 
three genes has the potential to fold into secondary structures 
that involve the 5' and 3' boundaries paired with each other 
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(mouse and human) or to other intronic sequences (rat) (Fig. 3). 
The sequestration of one or more of the splicing signals may 
prevent the recruiting of splicing factors and could therefore 
block splicing of this intron. It is conceivable that self-folding 
and the assembly of a splicing complex compete at this intron 
site, resulting in the co-existence of the two transcripts in the 
same cell. Formation of secondary structures has been pro- 
posed to explain the use of cryptic donor or acceptor sites or 
for alternative splicing (reviewed in [33]) but more importantly, 
secondary structures that sequester the 5' splice site in introns 
from yeast and plants block splicing [34,35]. 
Alternatively, splicing of this intron may require a specific 
splicing factor that is cell-specific or developmentally regulated 
such that, at any one time, only a subset of cells will be able 
to produce a fully functional transcript of the fll subunit. The 
presence of both transcripts in the B104 cell line is intriguing. 
B104 cells express a variety of Na currents with significant 
cell-to-cell heterogeneity, and it is possible that a fraction of 
those cells are unable to splice intron 5. Indeed only a subpop- 
ulation of B 104 is capable of producing an action potential (Gu 
et al., unpubl.). Whether the two fll transcripts co-exist in the 
same cell, and whether intron 5 effects the translation of fl~ 
remain to be determined. 
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